Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $14.5900 (1.89%) ($14.3400 - $14.8600) on Wed. Jun. 21, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 90 | Latest Price | $14.5900(1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2% a day on average for past five trading days. | Weekly Trend | HALO advances 5.2% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.255% in a week (0% probabilities). VIXM(-13%) UUP(-10%) TLT(-6%) SHY(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
5 Day Moving Average | $13.91(4.89%) | 10 Day Moving Average | $13.49(8.15%) | 20 Day Moving Average | $13.01(12.14%) | To recent high | 0% | To recent low | 23.6% | Market Cap | $1.994b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |